Jaguar Health extends note maturity to July 2025, reduces royalty balance by $1.09M via stock

Jaguar Health, Inc.

Issued 1,290,000 shares to a royalty holder in exchange for $1,094,952 reduction in outstanding royalty balance.
Entered Note Amendment with Streeterville Capital extending $6,220,812.50 secured promissory note maturity to July 20, 2025.
Note Amendment dated January 29, 2025, includes wholly-owned subsidiary Napo Pharmaceuticals as co-borrower.
Shares issued in the exchange rely on Section 3(a)(9) exemption from registration.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.